Prime Therapeutics earns URAC accreditation in pharmacy benefit management

By achieving this status, Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes. More about Prime's accreditation

News from Prime

Final FDA guidance is progress toward biosimilar access, competition

Once a biosimilar is designated as interchangeable, pharmacists may be able to automatically substitute the biosimilar for the reference brand — which should increase their utilization and may save health plans and their members money.

It’s number one, and that’s not a good thing

May is Arthritis Awareness month. Arthritis is the leading cause of disability in the United States and there are a few things you’ll want to know.

Jarrod Henshaw joins Prime Therapeutics as senior vice president, chief supply chain and industry relations officer

Henshaw will set the vision and provide strategic oversight for trade relations with pharmaceutical manufacturers, network management, pharmacy audit, and fraud, waste and abuse (FWA).